1. Home
  2. NKTX vs SKYX Comparison

NKTX vs SKYX Comparison

Compare NKTX & SKYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NKTX
  • SKYX
  • Stock Information
  • Founded
  • NKTX 2015
  • SKYX 2004
  • Country
  • NKTX United States
  • SKYX United States
  • Employees
  • NKTX N/A
  • SKYX N/A
  • Industry
  • NKTX Biotechnology: Pharmaceutical Preparations
  • SKYX Building Products
  • Sector
  • NKTX Health Care
  • SKYX Consumer Discretionary
  • Exchange
  • NKTX Nasdaq
  • SKYX Nasdaq
  • Market Cap
  • NKTX 123.5M
  • SKYX 139.3M
  • IPO Year
  • NKTX 2020
  • SKYX 2022
  • Fundamental
  • Price
  • NKTX $2.06
  • SKYX $1.13
  • Analyst Decision
  • NKTX Strong Buy
  • SKYX
  • Analyst Count
  • NKTX 5
  • SKYX 0
  • Target Price
  • NKTX $13.50
  • SKYX N/A
  • AVG Volume (30 Days)
  • NKTX 773.5K
  • SKYX 461.7K
  • Earning Date
  • NKTX 11-06-2025
  • SKYX 11-11-2025
  • Dividend Yield
  • NKTX N/A
  • SKYX N/A
  • EPS Growth
  • NKTX N/A
  • SKYX N/A
  • EPS
  • NKTX N/A
  • SKYX N/A
  • Revenue
  • NKTX N/A
  • SKYX $89,028,500.00
  • Revenue This Year
  • NKTX N/A
  • SKYX $10.92
  • Revenue Next Year
  • NKTX N/A
  • SKYX $25.51
  • P/E Ratio
  • NKTX N/A
  • SKYX N/A
  • Revenue Growth
  • NKTX N/A
  • SKYX 5.71
  • 52 Week Low
  • NKTX $1.31
  • SKYX $0.88
  • 52 Week High
  • NKTX $4.55
  • SKYX $2.14
  • Technical
  • Relative Strength Index (RSI)
  • NKTX 46.37
  • SKYX 44.93
  • Support Level
  • NKTX $2.10
  • SKYX $1.09
  • Resistance Level
  • NKTX $2.24
  • SKYX $1.17
  • Average True Range (ATR)
  • NKTX 0.10
  • SKYX 0.07
  • MACD
  • NKTX 0.01
  • SKYX -0.01
  • Stochastic Oscillator
  • NKTX 39.39
  • SKYX 20.69

About NKTX Nkarta Inc.

Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.

About SKYX SKYX Platforms Corp.

SKYX Platforms Corp operates in the business of developing proprietary technology that enables a quick and safe installation of electrical fixtures, such as light fixtures and ceiling fans. Its technology consists of a weight-bearing, fixable socket and a revolving plug for conducting electric power and supporting an electrical appliance attached to a wall or ceiling. The socket is comprised of a nonconductive body that houses conductive rings connectable to an electric power supply through terminals in its side exterior. The plug is also comprised of a nonconductive body that houses corresponding conductive rings, attaches to the socket via a male post, and is capable of feeding electric power to an appliance. It generates its income from lighting and heating products sold in the USA.

Share on Social Networks: